Sign in
CompletedNo phase

Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Status
Completed
People taking part
68 people enrolled
Started
8 Jul 2019
Ended
28 Mar 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Daytime Bright Light
  • Usual Light
Record updated
23 May 2024

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Hospital admission ≤30 hours at noon on enrollment day
  • Expected to say in the Medical Intensive Care Unit (MICU) ≥24 hours after enrollment
  • Age ≥50 years

Who cannot take part

  • At significant risk for pre-existing circadian abnormalities:; Severe chronic brain injury (Injury greater than 30 days ago resulting in the inability to live independently); Acute brain injury of any severity (Injury less than 30 days ago including acute intracranial bleed, traumatic brain injury, central nervous system infection, tumor); Documented circadian disorder or blind/disease of the optic nerve; Current history of substance abuse including alcohol (use in last 30 days)
  • Transferred from an outside hospital. 4. History of bipolar disease 5. Paralyzed (due to injury, disease or medications); Enrolled patients who do not stay in the MICU through 13:00 of Study Day 2 will be excluded; patients transferred from the MICU to the floor between 22:00 and 05:00 on subsequent study nights will continue in the study but be excluded from the primary analysis (estimated 10% of patients)

Where in United States

  • Yale New Haven Hospital - York Street CampusNew Haven, United States

About the trial

What the trial wants to find out

To determine if daytime bright light will promote circadian alignment and shorten or prevent delirium.

The 2 groups in the trial

  • Bright LightTreatment being tested

    Intervention: Daytime Bright Light Patients will be eligible if they were admitted within 30 hours of noon on enrollment day (e.g. at or after 06:00 on the prior calendar day). Enrollment will occur before noon, and the day of enrollment is termed study day 1. Patients will undergo monitoring (light levels, circadian alignment), starting on study day 1. Patients will be exposed to bright light from 09:00 to 13:00 starting on study day 2 and continuing through study day 5 or MICU discharge whichever is longer up to 30 days. Bright light exposure will occur in the Intensive Care Unit (ICU) and on the floor, if the patient is transferred (prior to study day 5). Feasibility metrics will also be collected.

    Treatment: Daytime Bright Light

  • Usual LightExisting treatment, for comparison

    Intervention: Usual Care Patients will be eligible if they were admitted within 30 hours of noon on enrollment day (e.g. at or after 06:00 on the prior calendar day). Enrollment will occur before noon, and the day of enrollment is termed study day 1. Patients will undergo monitoring (light levels, circadian alignment), but otherwise, have usual care.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
23 May 2024